Endovastec(SH:688016) Sou Hu Cai Jing·2025-12-24 12:36Core Viewpoint - The stock of Xinmai Medical (688016) has shown fluctuations in trading performance, with a recent closing price of 92.55 yuan, reflecting a 1.18% increase on December 24, 2025, amidst varying capital flows from different investor categories [1][2]. Group 1: Stock Performance and Capital Flow - On December 24, 2025, Xinmai Medical's stock closed at 92.55 yuan, with a trading volume of 7550 lots and a total transaction value of 69.46 million yuan [1]. - The net inflow of main funds was 1.87 million yuan, accounting for 2.69% of the total transaction value, while retail investors experienced a net outflow of 0.46 million yuan, representing 0.67% of the total [1]. - Over the past five days, the stock has seen significant fluctuations, with a peak net inflow of 2.99% on December 19, 2025, and a notable net outflow of 18.12% on December 23, 2025 [2]. Group 2: Financial Metrics and Industry Comparison - Xinmai Medical's total market capitalization is 11.408 billion yuan, slightly above the industry average of 10.878 billion yuan, ranking 28th out of 125 companies in the medical device sector [3]. - The company reported a net profit of 429 million yuan, significantly higher than the industry average of 210 million yuan, ranking 16th in the industry [3]. - The gross profit margin for Xinmai Medical stands at 70.4%, well above the industry average of 51.02%, indicating strong profitability [3]. Group 3: Recent Ratings and Analyst Outlook - In the last 90 days, eight institutions have rated Xinmai Medical, with six giving a "buy" rating and two an "accumulate" rating, suggesting a generally positive outlook [4]. - The average target price set by institutions over the past 90 days is 136.03 yuan, indicating potential upside from the current trading price [4].